Literature DB >> 28667380

Variants in the non-coding region of the TLR2 gene associated with infectious subphenotypes in pediatric sickle cell anemia.

Susana David1,2, Pedro Aguiar3, Liliana Antunes4, Alexandra Dias5, Anabela Morais6, Anavaj Sakuntabhai7,8, João Lavinha9,10.   

Abstract

Sickle cell anemia (SCA) is characterized by chronic hemolysis, severe vasoocclusive crises (VOCs), and recurrent often severe infections. A cohort of 95 SCA pediatric patients was the background for genotype-to-phenotype association of the patient's infectious disease phenotype and three non-coding polymorphic regions of the TLR2 gene, the -196 to -174 indel, SNP rs4696480, and a (GT)n short tandem repeat. The infectious subphenotypes included (A) recurrent respiratory infections and (B) severe bacterial infection at least once during the patient's follow-up. The absence of the haplotype [Del]-T-[n ≥ 17] (Hap7) in homozygocity protected against subphenotype (B), in a statistically significant association, resisting correction for multiple testing. For the individual loci, the same association tendencies were observed as in the haplotype, including a deleterious association between the SNP rs4696480 T allele and subphenotype (A), whereas the A/A genotype was protective, and a deleterious effect of the A/T genotype with subphenotype (B), as well as including the protective effect of -196 to -174 insert (Ins) and deleterious effect of the deletion (Del) in homozygocity, against subphenotype (B). Moreover, a reduction in the incidence rate of severe bacterial infection was associated to a rise in the hemolytic score, fetal hemoglobin levels (prior to hydroxyurea treatment), and 3.7-kb alpha-thalassemia. Interestingly, differences between the effects of the two latter covariables favoring a reduction in the incidence rate of subphenotype (B) contrast with a resulting increase in relation to subphenotype (A). These results could have practical implications in health care strategies to lower the morbidity and mortality of SCA patients.

Entities:  

Keywords:  Genetic variants; Genotype-to-phenotype association; Hemolytic component; Sickle cell anemia; TLR2; Viral and bacterial infection

Mesh:

Substances:

Year:  2017        PMID: 28667380     DOI: 10.1007/s00251-017-1013-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   3.330


  69 in total

Review 1.  Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

2.  Role of infections in the induction and development of asthma: genetic and inflammatory drivers.

Authors:  Qun Wu; Hong Wei Chu
Journal:  Expert Rev Clin Immunol       Date:  2009-01-01       Impact factor: 4.473

3.  Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis.

Authors:  H D Nischalke; C Berger; K Aldenhoff; L Thyssen; M Gentemann; F Grünhage; F Lammert; J Nattermann; T Sauerbruch; U Spengler; B Appenrodt
Journal:  J Hepatol       Date:  2011-02-26       Impact factor: 25.083

4.  A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.

Authors:  K R Bridges; G D Barabino; C Brugnara; M R Cho; G W Christoph; G Dover; B M Ewenstein; D E Golan; C R Guttmann; J Hofrichter; R V Mulkern; B Zhang; W A Eaton
Journal:  Blood       Date:  1996-12-15       Impact factor: 22.113

5.  Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans.

Authors:  Digna Rosa Velez; Christian Wejse; Martin E Stryjewski; Eduardo Abbate; William F Hulme; Jamie L Myers; Rosa Estevan; Sara G Patillo; Rikke Olesen; Alessandra Tacconelli; Giorgio Sirugo; John R Gilbert; Carol D Hamilton; William K Scott
Journal:  Hum Genet       Date:  2009-09-22       Impact factor: 4.132

Review 6.  Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer.

Authors:  Andrei E Medvedev
Journal:  J Interferon Cytokine Res       Date:  2013-05-15       Impact factor: 2.607

7.  The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.

Authors:  Mehdi Nouraie; Janet S Lee; Yingze Zhang; Tamir Kanias; Xuejun Zhao; Zeyu Xiong; Timothy B Oriss; Qilu Zeng; Gregory J Kato; J Simon R Gibbs; Mariana E Hildesheim; Vandana Sachdev; Robyn J Barst; Roberto F Machado; Kathryn L Hassell; Jane A Little; Dean E Schraufnagel; Lakshmanan Krishnamurti; Enrico Novelli; Reda E Girgis; Claudia R Morris; Erika Berman Rosenzweig; David B Badesch; Sophie Lanzkron; Oswaldo L Castro; Jonathan C Goldsmith; Victor R Gordeuk; Mark T Gladwin
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

8.  Herpes simplex virus 2-induced activation in vaginal cells involves Toll-like receptors 2 and 9 and DNA sensors DAI and IFI16.

Authors:  Kathy Triantafilou; Dilan Eryilmazlar; Martha Triantafilou
Journal:  Am J Obstet Gynecol       Date:  2013-09-28       Impact factor: 8.661

9.  Quasi-Poisson vs. negative binomial regression: how should we model overdispersed count data?

Authors:  Jay M Ver Hoef; Peter L Boveng
Journal:  Ecology       Date:  2007-11       Impact factor: 5.499

Review 10.  Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer.

Authors:  Luke A J O'Neill; Clare E Bryant; Sarah L Doyle
Journal:  Pharmacol Rev       Date:  2009-05-27       Impact factor: 25.468

View more
  1 in total

1.  Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease.

Authors:  Karina Tozatto-Maio; Robert Girot; Indou Deme Ly; Ana Cristina Silva Pinto; Vanderson Rocha; Francisco Fernandes; Ibrahima Diagne; Yahia Benzerara; Carla L Dinardo; Julia Pavan Soler; Simone Kashima; Itauá Leston Araujo; Chantal Kenzey; Guilherme H H Fonseca; Evandra S Rodrigues; Fernanda Volt; Luciana Jarduli; Annalisa Ruggeri; Christina Mariaselvam; Sandra F M Gualandro; Hanadi Rafii; Barbara Cappelli; Felipe Melo Nogueira; Graziana Maria Scigliuolo; Renato Luiz Guerino-Cunha; Kelen Cristina Ribeiro Malmegrim; Belinda P Simões; Eliane Gluckman; Ryad Tamouza
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.